Nathan Price, PhD







Nathan Price is a Professor and Assistant Director of the Institute for Systems Biology in Seattle, WA. Dr. Price is the recipient of numerous awards including the Howard Temin Pathway to Independence Award in Cancer Research from the National Institutes of Health, a national Science Foundation CAREER award, a Young Investigator award from the Roy J. Carver Charitable Trust, and was named as one of the inaugural “Tomorrow’s Principal Investigators” by Genome Technology and, most recently, as a Camille-Dreyfus Teacher-Scholar. Dr. Price served on the National Academies-Institute of Medicine Committee to set best practice guidelines to identify Omics-based Tests for Predicting Patient Outcomes in Clinical Trials. Dr. price has served on the scientific advisory boards of a number of companies and institutes including TetraVitae Bioscience, Trelys, and the Novo Nordisk Foundation Center for Biosustainability. He serves on the editorial boards of Science Translational Medicine, Cell Systems, IEEE Life Science Letters, BMC Systems Biology, Industrial Biotechnology, Biotechnology Journal, and was previously Deputy Editor of PLOS Computational Biology from 2011-2014. He has served for several years on the Board of Directors and Scientific Advisory Board of the P4 Medicine Institute. Dr. Price is also co-PI of ISB’s 100K Wellness study, which is a pioneering effort to predict and prevent disease before it happens.